 | • レポートコード：QYR9ST03633 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、てんかん治療の世界市場について調査・分析し、てんかん治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗てんかん薬、栄養補助食品、迷走神経刺激、外科療法）、用途別（病院、神経センター、在宅ケアの設定、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のてんかん治療市場動向 ・主要企業別マーケットシェア ・てんかん治療の種類別市場規模2014-2019 （抗てんかん薬、栄養補助食品、迷走神経刺激、外科療法） ・てんかん治療の用途別市場規模2014-2019 （病院、神経センター、在宅ケアの設定、外来手術センター） ・てんかん治療の北米市場：主要企業・種類別/用途別市場規模 ・てんかん治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・てんかん治療の中国市場：主要企業・種類別/用途別市場規模 ・てんかん治療の日本国内市場：主要企業・種類別/用途別市場規模 ・てんかん治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・てんかん治療のインド市場：主要企業・種類別/用途別市場規模 ・てんかん治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott Laboratories、Cephalon、Novartis、Pfizer、Johnson & Johnson、GlaxoSmithKline、Sanofi、Sunovion Pharmaceuticals、Valeant Pharmaceuticals、Shire） ・てんかん治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized).Neurological disorders treatment market is growing at a significant rate, due to increasing prevalence of neurological disorders and technological advancements in the treatment of these conditions.
United States dominates the global market for epilepsy therapeutics due to increasing prevalence of epilepsy cases in the region.
China and India are expected to be the fastest growing epilepsy therapeutics markets in the Asia. This is due to the large population base and increasing prevalence of epilepsy cases in these countries.
In 2018, the global Epilepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epilepsy Therapeutics development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Cephalon
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Sanofi
Sunovion Pharmaceuticals
Valeant Pharmaceuticals
Shire
Market segment by Type, the product can be split into
Anti-epileptic Drugs
Dietary Supplements
Vagal Nerve Stimulation
Surgical Therapies
Market segment by Application, split into
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Epilepsy Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Epilepsy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Epilepsy Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-epileptic Drugs
1.4.3 Dietary Supplements
1.4.4 Vagal Nerve Stimulation
1.4.5 Surgical Therapies
1.5 Market by Application
1.5.1 Global Epilepsy Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Neurology Centers
1.5.4 Home Care Settings
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Epilepsy Therapeutics Market Size
2.2 Epilepsy Therapeutics Growth Trends by Regions
2.2.1 Epilepsy Therapeutics Market Size by Regions (2014-2025)
2.2.2 Epilepsy Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Epilepsy Therapeutics Market Size by Manufacturers
3.1.1 Global Epilepsy Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Epilepsy Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Epilepsy Therapeutics Key Players Head office and Area Served
3.3 Key Players Epilepsy Therapeutics Product/Solution/Service
3.4 Date of Enter into Epilepsy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Epilepsy Therapeutics Market Size by Type (2014-2019)
4.2 Global Epilepsy Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Epilepsy Therapeutics Market Size (2014-2019)
5.2 Epilepsy Therapeutics Key Players in United States
5.3 United States Epilepsy Therapeutics Market Size by Type
5.4 United States Epilepsy Therapeutics Market Size by Application
6 Europe
6.1 Europe Epilepsy Therapeutics Market Size (2014-2019)
6.2 Epilepsy Therapeutics Key Players in Europe
6.3 Europe Epilepsy Therapeutics Market Size by Type
6.4 Europe Epilepsy Therapeutics Market Size by Application
7 China
7.1 China Epilepsy Therapeutics Market Size (2014-2019)
7.2 Epilepsy Therapeutics Key Players in China
7.3 China Epilepsy Therapeutics Market Size by Type
7.4 China Epilepsy Therapeutics Market Size by Application
8 Japan
8.1 Japan Epilepsy Therapeutics Market Size (2014-2019)
8.2 Epilepsy Therapeutics Key Players in Japan
8.3 Japan Epilepsy Therapeutics Market Size by Type
8.4 Japan Epilepsy Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Epilepsy Therapeutics Market Size (2014-2019)
9.2 Epilepsy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Epilepsy Therapeutics Market Size by Type
9.4 Southeast Asia Epilepsy Therapeutics Market Size by Application
10 India
10.1 India Epilepsy Therapeutics Market Size (2014-2019)
10.2 Epilepsy Therapeutics Key Players in India
10.3 India Epilepsy Therapeutics Market Size by Type
10.4 India Epilepsy Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Epilepsy Therapeutics Market Size (2014-2019)
11.2 Epilepsy Therapeutics Key Players in Central & South America
11.3 Central & South America Epilepsy Therapeutics Market Size by Type
11.4 Central & South America Epilepsy Therapeutics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Epilepsy Therapeutics Introduction
12.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Cephalon
12.2.1 Cephalon Company Details
12.2.2 Company Description and Business Overview
12.2.3 Epilepsy Therapeutics Introduction
12.2.4 Cephalon Revenue in Epilepsy Therapeutics Business (2014-2019)
12.2.5 Cephalon Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Epilepsy Therapeutics Introduction
12.3.4 Novartis Revenue in Epilepsy Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Epilepsy Therapeutics Introduction
12.4.4 Pfizer Revenue in Epilepsy Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Epilepsy Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Epilepsy Therapeutics Introduction
12.6.4 GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Epilepsy Therapeutics Introduction
12.7.4 Sanofi Revenue in Epilepsy Therapeutics Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Sunovion Pharmaceuticals
12.8.1 Sunovion Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Epilepsy Therapeutics Introduction
12.8.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)
12.8.5 Sunovion Pharmaceuticals Recent Development
12.9 Valeant Pharmaceuticals
12.9.1 Valeant Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Epilepsy Therapeutics Introduction
12.9.4 Valeant Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)
12.9.5 Valeant Pharmaceuticals Recent Development
12.10 Shire
12.10.1 Shire Company Details
12.10.2 Company Description and Business Overview
12.10.3 Epilepsy Therapeutics Introduction
12.10.4 Shire Revenue in Epilepsy Therapeutics Business (2014-2019)
12.10.5 Shire Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Epilepsy Therapeutics Key Market Segments
Table Key Players Epilepsy Therapeutics Covered
Table Global Epilepsy Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Epilepsy Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-epileptic Drugs Figures
Table Key Players of Anti-epileptic Drugs
Figure Dietary Supplements Figures
Table Key Players of Dietary Supplements
Figure Vagal Nerve Stimulation Figures
Table Key Players of Vagal Nerve Stimulation
Figure Surgical Therapies Figures
Table Key Players of Surgical Therapies
Table Global Epilepsy Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Neurology Centers Case Studies
Figure Home Care Settings Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Epilepsy Therapeutics Report Years Considered
Table Global Epilepsy Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Epilepsy Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Epilepsy Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Epilepsy Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Epilepsy Therapeutics Market Share by Regions 2014-2019
Figure Global Epilepsy Therapeutics Market Share by Regions 2014-2019
Figure Global Epilepsy Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Epilepsy Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Epilepsy Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Epilepsy Therapeutics Market Share by Manufacturers in 2018
Table Global Epilepsy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Epilepsy Therapeutics Product/Solution/Service
Table Date of Enter into Epilepsy Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Epilepsy Therapeutics Market Size Share by Type (2014-2019)
Figure Global Epilepsy Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Epilepsy Therapeutics Market Size Share by Application (2014-2019)
Figure Global Epilepsy Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Epilepsy Therapeutics Revenue Market Share by Application in 2018
Figure United States Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table United States Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Epilepsy Therapeutics Market Share by Type (2014-2019)
Table United States Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Europe Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Europe Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Europe Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure China Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table China Epilepsy Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Epilepsy Therapeutics Market Share by Type (2014-2019)
Table China Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Japan Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Japan Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Japan Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Southeast Asia Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure India Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table India Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Epilepsy Therapeutics Market Share by Type (2014-2019)
Table India Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Epilepsy Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Epilepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Epilepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Epilepsy Therapeutics Market Share (2018-2019)
Table Central & South America Epilepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Epilepsy Therapeutics Market Share by Type (2014-2019)
Table Central & South America Epilepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Epilepsy Therapeutics Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Cephalon Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Cephalon Recent Development
Table Novartis Company Details
Table Novartis Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Sunovion Pharmaceuticals Company Details
Table Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Sunovion Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Shire Company Details
Table Shire Revenue in Epilepsy Therapeutics Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Epilepsy Therapeutics Business (2014-2019)
Table Shire Recent Development
Table Global Epilepsy Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Epilepsy Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Epilepsy Therapeutics Market Size Share by Regions in 2025
Figure United States Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Epilepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Epilepsy Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Epilepsy Therapeutics Market Size by Product (2019-2025)
Figure Global Epilepsy Therapeutics Market Size by Product in 2025
Table Global Epilepsy Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Epilepsy Therapeutics Market Size by Application (2019-2025)
Figure Global Epilepsy Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
てんかん薬の世界市場：市場規模・現状・予測 Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…- てんかん治療の世界市場：市場規模・現状・予測 Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- 変形性関節症再生療法の世界市場：市場規模・現状・予測 Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. In 2018, the global Regenerative Therapies for Osteoarthritis market size…
- 変形性関節症再生療法の世界市場：市場規模・現状・予測 Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. In 2018, the global Regenerative Therapies for Osteoarthritis market size…
- 緑内障治療薬の世界市場：市場規模・現状・予測 Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics glob…